Clinical Trials · NCT06542874
A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 448
- Start date
- Aug 2024
- Locations
- 137 sites, 11 countries
- Primary endpoint
- Change in HbA1c